Alembic Pharmaceuticals Ltd (APLLTD)
₹1175.4▲8.34%
Analyst Rating
based on 13 analysts
28.57%
Buy
42.86%
Hold
28.57%
Sell
Based on 13 analysts offering long term price targets for Alembic Pharmaceuticals Ltd. An average target of ₹985.08
Source: S&P Global Market Intelligence
Alembic Pharmaceuticals Ltd Share analysis
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹1,072.9₹1,192.9552 Week's Low
52 Week's High
₹682.3₹1,192.95
| Returns % | |
| 1 Month Return | + 20.21 % |
| 3 Month Return | + 13.25 % |
| 1 Year Return | + 57.81 % |
| Market Stats | |
| Previous Close | ₹1,084.95 |
| Open | ₹1,072.90 |
| Volume | 13.19L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹21,326.12Cr |
Key Statistics
| P/E Ratio | 35.23 |
| PEG Ratio | 2.63 |
| Market Cap | ₹21,326.12 Cr |
| P/B Ratio | 3.93 |
| EPS | 42.47 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹21,326.12 Cr | 21.12% | 0.55 | ₹615 Cr | ₹6,228 Cr |
 | BUY | ₹14,715.36 Cr | 1.19% | 0.52 | ₹602 Cr | ₹2,851 Cr |
 | BUY | ₹79,555.81 Cr | 29.52% | 0.60 | ₹1,927 Cr | ₹24,855 Cr |
 | HOLD | ₹1,15,601.19 Cr | 80.1% | 0.64 | ₹3,854 Cr | ₹19,547 Cr |
 | BUY | ₹58,923.70 Cr | 44.27% | 0.53 | NA | NA |
Company Information
Share Price: ₹1175.40 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹21,326.12Cr as of today
Revenue: ₹1,516.98Cr as on March 2024 (Q1 24)
Net Profit: ₹178.21Cr as on March 2024 (Q1 24)
Listing date: 20 Sep, 2011
Chairperson Name: Chirayu R Amin
| Organisation | Alembic Pharmaceuticals Ltd |
| Headquarters | Vadodara |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Receives 11 USFDA Product Approvals - 03 Jul, 2024
During the quarter ended June 30, 2024, Alembic Pharmaceuticals received 11 USFDA product approvals for various indications including acne vulgaris, anxiety disorders, pulmonary arterial hypertension, melanoma, heart failure, neoplastic diseases, and more.
Alembic Pharma Receives FDA Approval for Blood Clot Prevention Drug - 18 Jun, 2024
Alembic Pharmaceuticals has received final approval from the USFDA for its ANDA concerning Dabigatran Etexilate Capsules and is expected to target a market size of $179 million. The stock saw a 6.4 times surge in volume.
Insights on Alembic Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 7.82% to 8.05% in Jun 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, APLLTD stock has moved up by 20.2%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 10.54% to 10.60% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 29.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.61% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 108.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 180.45 Cr → 178.21 Cr (in ₹), with an average decrease of 1.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.63K Cr → 1.52K Cr (in ₹), with an average decrease of 6.9% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 4.46% to 4.32% in Jun 2024 quarter
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹1,516.98Cr | ↓6.97% |
Net Income | ₹178.21Cr | ↓1.24% |
Net Profit Margin | 11.75% | ↑6.14% |
| 2024 | Y/Y Change | |
|---|---|---|
Revenue | ₹6,228.63Cr | ↑10.19% |
Net Income | ₹615.82Cr | ↑80.07% |
Net Profit Margin | 9.89% | ↑63.47% |
| 2024 | Y/Y Change | |
|---|---|---|
Total Assets | ₹6,529.82Cr | ↑5.09% |
Total Liabilities | ₹1,620.91Cr | ↓9.91% |
| 2024 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹772.77Cr | ↑5.82% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.61% | 0.00 | |
| Foreign Institutions | 4.32% | ||
| Mutual Funds | 8.05% | 2.94 | |
| Retail Investors | 10.6% | 0.56 | |
| Others | 7.42% |
Key Indicators
Alembic Pharmaceuticals Ltd Valuation
Alembic Pharmaceuticals Ltd in the last 5 years
Lowest (11.53x)
March 23, 2020
Today (35.23x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (53.41x)
January 3, 2023
Earnings and Dividends
Alembic Pharmaceuticals Ltd Earnings Results
Alembic Pharmaceuticals Ltd’s net profit jumped 16.78% since last year same period to ₹178.21Cr in the Q4 2023-2024. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -1.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlembic Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Alembic Pharmaceuticals Ltd has declared dividend of ₹11 - translating a dividend yield of 1.01%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Alembic Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Alembic Pharmaceuticals Ltd shares.
Alembic Pharmaceuticals Ltd (APLLTD) share price today is ₹1175.4
Alembic Pharmaceuticals Ltd is listed on NSE
Alembic Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Alembic Pharmaceuticals Ltd is ₹1192.95.
- Today’s lowest price of Alembic Pharmaceuticals Ltd is ₹1072.9.
PE Ratio of Alembic Pharmaceuticals Ltd is 35.23
PE ratio = Alembic Pharmaceuticals Ltd Market price per share / Alembic Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Alembic Pharmaceuticals Ltd(APLLTD) is 13.19L.
Today’s market capitalisation of Alembic Pharmaceuticals Ltd(APLLTD) is ₹21326.12Cr.
| Alembic Pharmaceuticals Ltd(APLLTD | Price |
|---|---|
52 Week High | ₹1192.95 |
52 Week Low | ₹682.3 |
Alembic Pharmaceuticals Ltd(APLLTD) share price is ₹1175.4. It is down -1.47% from its 52 Week High price of ₹1192.95
Alembic Pharmaceuticals Ltd(APLLTD) share price is ₹1175.4. It is up 72.27% from its 52 Week Low price of ₹682.3
| Alembic Pharmaceuticals Ltd(APLLTD | Returns |
|---|---|
1 Day Returns | 90.45% |
1 Month Returns | 20.21% |
3 Month Returns | 13.25% |
1 Year Returns | 57.81% |